Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19)
Clinical trial NCT04323761 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT04323761
- Sponsor
- Gilead Sciences
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.